Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company 

The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse and diversion seen with opioids, nor the opioid-induced side effects, including potentially life-threatening respiratory depression.  Neumentum’s assets include 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world.